Affiliation:
1. Department of Pharmacology, School of Medicine, Leeds, LS2 9NL, UK
Abstract
Abstract
3,3′,5,5′-Tetramethylstilboestrol (I) and its α,α′-dimethyl- (II) and α,α′-diethyl- homologues (III) have been tested for oestrogenic and anti-oestrogenic activity. α,α′-Diethyl-3,3′,5,5′-tetramethylstilboestrol (III), by the uterine weight assay in immature mice, is 2·1 times 10−4 times as potent as an oestrogen as 17β-oestradiol [fiducial limits (0·95) = 1·59 times 10−4 −2·74 times 10−4] but 3,3′,5,5′-tetramethylstilboestrol (I) and α,α′,3,3′,5,5′-hexamethylstilboestrol (II) were oestrogenically inactive at a dose of 0·8 mg. Compound III exhibited auto-inhibition of its own oestrogenic response at doses between 1·8 and 7·2 mg. None of the compounds tested inhibited the uterotrophic response to 17β-oestradiol. Compounds II and III, but not compound I, produced a highly significant inhibition of the vaginal cornification response to 17β-oestradiol when the test compounds (5 μg) and 17β-oestradiol were administered intra-vaginally in a single solution. It is suggested that the compounds II and III compete with 17β-oestradiol for the oestrogen receptor and that methyl groups positioned ortho to the phenolic hydroxyl group sterically interfere with the binding of the compounds to the oestrogen receptor, or with the initiation of the oestrogenic response, or both.
Publisher
Oxford University Press (OUP)
Subject
Pharmaceutical Science,Pharmacology
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献